Private Wealth Management Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Private Wealth Management Group’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22	Closed	-$2.9K	–	1624
2025 Q1	$2.9K	Hold	22	–	–	﹤0.01%	932
2024 Q4	$1.84K	Sell	22 -15	-41%	-$1.23K	﹤0.01%	1110
2024 Q3	$2.71K	Hold	37	–	–	﹤0.01%	958
2024 Q2	$2.54K	Buy	37 +22	+147%	+$1.53K	﹤0.01%	967
2024 Q1	$1.04K	Hold	15	–	–	﹤0.01%	1254
2023 Q4	$1.07K	Buy	+15	New	+$863	﹤0.01%	1242

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Private Wealth Management Group's ITCI Position: Q2 2025 in Review

Private Wealth Management Group sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 22 shares — an estimated $2.9K sold.

Private Wealth Management Group first reported a position in ITCI in Q4 2023 and held it in 6 quarters. The position peaked at $2.9K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Private Wealth Management Group reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Private Wealth Management Group sold 22 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $2.9K.
Private Wealth Management Group first reported a position in Intra-Cellular Therapies Inc. in Q4 2023 and held it in 6 quarters.
Private Wealth Management Group's Intra-Cellular Therapies Inc. position peaked at $2.9K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Private Wealth Management Group's 13F filing for Q2 2025, filed 29 Jul 2025.